ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag federal funding genetics genomics microbiology disease medicine

bacteria and DNA molecules on a purple background.
Engineering the Microbiome: CRISPR Leads the Way
Mariella Bodemeier Loayza Careaga, PhD | Mar 15, 2024 | 10+ min read
Scientists have genetically modified isolated microbes for decades. Now, using CRISPR, they intend to target entire microbiomes.
Haydeh Payami is wearing a purple dress and an orange and pink scarf and standing in front of a whiteboard.
A Microbial Link to Parkinson’s Disease
Mariella Bodemeier Loayza Careaga, PhD | Dec 4, 2023 | 6 min read
Haydeh Payami helped uncover the genetic basis of Parkinson’s disease. Now, she hopes to find new ways to treat the disease by studying the gut microbiome.
A Geneticist’s Quest to Understand His Son’s Mysterious Disease
Tracie White | Jan 1, 2021 | 4 min read
Ronald Davis of Stanford University changed his focus to research on ME/CFS, the disease formerly known as chronic fatigue syndrome, in a bid to help his son and others like him.
2022 Top 10 Innovations 
2022 Top 10 Innovations
The Scientist | Dec 12, 2022 | 10+ min read
This year’s crop of winning products features many with a clinical focus and others that represent significant advances in sequencing, single-cell analysis, and more.
Researchers in George Church&rsquo;s lab modified wild type ADK proteins (left) in <em >E.coli</em>, furnishing them with an nonstandard amino acid (nsAA) meant to biocontain the resulting bacterial strain.
A Pioneer of The Multiplex Frontier
Rashmi Shivni, Drug Discovery News | May 20, 2023 | 10 min read
George Church is at it again, this time using multiplex gene editing to create virus-proof cells, improve organ transplant success, and protect elephants.
Opinion: Hunting a Changing Virus
Libusha Kelly | Jul 1, 2021 | 3 min read
A broad and nimble sequencing program is necessary to track, anticipate, and quash SARS-CoV-2 and other dangerous pathogens that threaten humanity.
Best Places to Work Industry, 2011
Hannah Waters | May 1, 2011 | 9 min read
By forging new relationships and finding novel uses for existing technologies, this year’s top companies are employing creative ways to advance their science.
USDA Proposes Ambitious New Plant Genome Initiative
Christopher Anderson | Aug 6, 1989 | 4 min read
WASHINGTON-In an ambitious answer to the National Institutes of Health's Human Genome Project, the U.S. Department of Agriculture has sprouted plans for a parallel project to map the genetic structure of key food plants. The proposal, presented by USDA program manager Jerome Miksche at a meeting of the NIH genome project's advisory committee in June, would identify genetic traits that can increase yield and disease resistance. The price tag is estimated to be $500 million over 10 years. In recen
Illustration of DNA
Can “Gene Writing” Deliver What Gene Editing Can’t?
Dan Robitzski | Dec 12, 2022 | 10+ min read
A biotech startup called Tessera Therapeutics has made a splash with its claims about the trademarked technology. Is the excitement justified?
Scientific Medicine and Chronic Fatigue Syndrome
Mary Mcnamara | Nov 12, 2000 | 6 min read
Illustration: A. Canamucio There has never been a better time, technologically, for our federal health agencies to launch a significant effort to prevent and control a chronic disease that has inflicted suffering on mankind for centuries. Chronic fatigue syndrome (CFS) is the current name for an illness with many names and a long history. In 1681 Thomas Sydenham, founder of modern clinical, scientific, and public health medicine, described a disease spectrum identical to it called "muscular rheu

Run a Search

ADVERTISEMENT